Cyclopharm Limited Investor Relations Material

Cyclopharm Limited is an Australia-based health technology company primarily engaged in the manufacture and sale of medical equipment and radiopharmaceuticals. The company operates through two main segments: Technegas and Molecular Imaging. The Technegas segment focuses on providing diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. It also distributes products to the diagnostic imaging sector. The Molecular Imaging segment is involved in producing radiopharmaceuticals for the detection of cancer, neurological disorders, and cardiac disease. The company is headquartered in Kingsgrove, New South Wales, and its shares are listed on the ASX.